Dakota Wealth Management decreased its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report) by 1.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 45,166 shares of the real estate investment trust’s stock after selling 550 shares during the quarter. Dakota Wealth Management’s holdings in Sabra Healthcare REIT were worth $833,000 at the end of the most recent quarter.
Other institutional investors have also bought and sold shares of the company. Nuveen LLC bought a new position in shares of Sabra Healthcare REIT during the first quarter worth about $61,791,000. Jefferies Financial Group Inc. lifted its position in shares of Sabra Healthcare REIT by 7,196.8% in the first quarter. Jefferies Financial Group Inc. now owns 1,466,000 shares of the real estate investment trust’s stock valued at $25,611,000 after buying an additional 1,445,909 shares during the last quarter. Swedbank AB acquired a new stake in shares of Sabra Healthcare REIT in the first quarter valued at approximately $19,336,000. Retirement Systems of Alabama lifted its position in shares of Sabra Healthcare REIT by 243.3% in the first quarter. Retirement Systems of Alabama now owns 987,655 shares of the real estate investment trust’s stock valued at $17,254,000 after buying an additional 699,985 shares during the last quarter. Finally, Advisors Capital Management LLC increased its stake in shares of Sabra Healthcare REIT by 20.5% during the first quarter. Advisors Capital Management LLC now owns 2,232,609 shares of the real estate investment trust’s stock worth $39,004,000 after purchasing an additional 380,505 shares during the period. Institutional investors and hedge funds own 99.40% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts have recently weighed in on SBRA shares. JMP Securities increased their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a “market outperform” rating in a research note on Wednesday, August 6th. BMO Capital Markets raised their price objective on Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a “market perform” rating in a research note on Monday, August 25th. Truist Financial raised their price objective on Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a “hold” rating in a research note on Tuesday, September 2nd. Wells Fargo & Company raised their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 27th. Finally, Scotiabank raised their price objective on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a “sector perform” rating in a research note on Monday, June 23rd. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $20.83.
Sabra Healthcare REIT Trading Up 0.9%
NASDAQ SBRA opened at $18.83 on Friday. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT, Inc. has a twelve month low of $15.60 and a twelve month high of $20.03. The company has a market cap of $4.52 billion, a price-to-earnings ratio of 24.78, a price-to-earnings-growth ratio of 1.50 and a beta of 0.88. The business’s fifty day moving average is $18.76 and its 200 day moving average is $18.12.
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last announced its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, topping the consensus estimate of $0.36 by $0.02. The firm had revenue of $189.15 million for the quarter, compared to the consensus estimate of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The business’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.36 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, sell-side analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.
Sabra Healthcare REIT Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Friday, August 15th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.4%. The ex-dividend date of this dividend was Friday, August 15th. Sabra Healthcare REIT’s payout ratio is currently 157.89%.
Sabra Healthcare REIT Profile
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Featured Articles
- Five stocks we like better than Sabra Healthcare REIT
- The 3 Best Retail Stocks to Shop for in August
- 3 Healthcare Stocks Using AI to Drive Growth
- Canadian Penny Stocks: Can They Make You Rich?
- Get Exposure to Millennials’ Purchasing Power With This ETF
- 3 Fintech Stocks With Good 2021 Prospects
- Why a $4.5 Billion Smart Debt Move Is Fueling Dell’s AI Ambitions
Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report).
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.